H. Rept. 116-512: Safeguarding Therapeutics Act, Report to Accompany H.R. 5663, September 17, 2020 [open pdf - 336KB]
From the Purpose and Summary: "H.R. 5663, the 'Safeguarding Therapeutics Act', was introduced on January 21, 2020, by Representatives Brett Guthrie (R-KY) and Eliot L. Engel (D-NY). H.R. 5663, as reported, will extend the administrative destruction authority of the U.S. Food and Drug Administration (FDA) to medical devices. This authority allows the agency to destroy drugs or devices that have been refused admission without providing the owner or consignee with the opportunity to export the product. This authority helps the agency to ensure that counterfeit or otherwise violative products cannot enter the United States."
H. Rept. 116-512; House Report 116-512
U.S. Government Publishing Office: http://www.gpo.gov/